| 영문 | adverse effect | 한글 | 역효과, 유해효과 |
|---|---|---|---|
| 설명 | 약물에 의한 치료를 할 때 나타나는 치료목적에 부합되지 않는 불쾌한 작용, 즉 부작용을 역효과로 표현하는 경우가 있다. 세계보건기구(WHO)에서는 역효과란 “예방, 진단, 치료의 목적으로 사람에게 상용량의 약을 사용하였을 때 발현하는 장애로, 의도하지 않은 작용”이라고 정의하고 있다. 약물에 의한 치료를 할 때, 특히 주목하여야 할 일반적인 역효과로서 약물알레르기, 조혈장기 장애, 간-콩팥의 장애, 물질 대사 장애 등이 있다. 이 외에 임산부에게 투여하여 발생한 기형발생, 마약, 각성제, 기타 향정신제에 의한 의존성 형성도 중요하다. |
||
| 영문 | shunt | 한글 | 지름길, 지름술, 단락 |
|---|---|---|---|
| 설명 | 1. 한쪽으로 돌아가다, 전환하다, 우회하다. 2. 혈관간의 통로 또는 연결. |
||
| B-T shunt | Blalock-Taussig shunt |
|---|---|
| HMP Shunt | Hexose Mono-Phosphate Shunt |
| LP shunt | Lumbo-Peritoneal shunt |
| VA shunt | Ventriculo-Atrial shunt |
| VP shunt | Ventriculo-Peritoneal shunt |
| DSRS | Distal splenorenal shunt |
|---|---|
| HMPS | Hexose monophosphate shunt |
| HMS | Hexose-monophosphate shunt |
| PVS | Peritoneo Venous Shunt |
| PCS | Portacaval shunt |
| arteriovenous shunt | <anatomy, surgery> A direct connection between an artery and vein. Most often due to the surgical joining of an artery and a vein under the skin for the purpose of haemodialysis. Larger arteriovenous shunts can create significant extra workload on the heart since arterial blood is diverted back to the venous circulation before it has a chance to deliver nutrients and oxygen to the body tissues. (20 Jun 2000) |
|---|---|
| A-V shunt | <anatomy, surgery> A direct connection between an artery and vein. Most often due to the surgical joining of an artery and a vein under the skin for the purpose of haemodialysis. Larger arteriovenous shunts can create significant extra workload on the heart since arterial blood is diverted back to the venous circulation before it has a chance to deliver nutrients and oxygen to the body tissues. (20 Jun 2000) |
| Blalock shunt | Subclavian artery to pulmonary artery shunt to increase pulmonary circulation in cyanotic heart disease with decreased pulmonary flow. (05 Mar 2000) |
| Blalock-Taussig shunt | A palliative subclavian artery to pulmonary artery anastomosis. (05 Mar 2000) |
| Rapoport-Luebering shunt | Part of the glycolytic pathway characteristic of human erythrocytes in which 2,3-bisphosphoglycerate (2,3-P2Gri) is formed as an intermediate between 1,3-P2Gri and 3-phosphoglycerate; 2,3-P2Gri is an important regulator of the affinity of haemoglobin for oxygen. (05 Mar 2000) |
| ventriculoperitoneal shunt | <procedure> A surgical procedure to insert a communicating catheter to relieve intracranial pressure caused by hydrocephalus. In this procedure the cerebrospinal fluid is shunted from the ventricles of the brain into the peritoneal cavity via a surgically implanted tube. (27 Sep 1997) |
| Glenn shunt | A means of palliating cyanotic heart disease by anastomosing the right pulmonary artery to the superior vena cava. Synonym: cavopulmonary shunt, Glenn shunt. (05 Mar 2000) |
| cavopulmonary shunt | A means of palliating cyanotic heart disease by anastomosing the right pulmonary artery to the superior vena cava. Synonym: cavopulmonary shunt, Glenn shunt. (05 Mar 2000) |
| renal-splenic venous shunt | Anastomosis of the splenic vein to the left renal vein, usually end-to-side, for control of portal hypertension. Synonym: renal-splenic venous shunt. (05 Mar 2000) |
| vp shunt | <procedure> A surgical procedure to insert a communicating catheter to relieve intracranial pressure caused by hydrocephalus. In this procedure the cerebrospinal fluid is shunted from the ventricles of the brain into the peritoneal cavity via a surgically implanted tube. (27 Sep 1997) |
| pentose monophosphate shunt | <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate. Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses. In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection. Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose. (18 Nov 1997) |
| reversed shunt | Right-to-left shunt that had previously been a left-to-right shunt; rarely the opposite. (05 Mar 2000) |
| mesocaval shunt | Anastomosis of the side of the superior mesenteric vein to the proximal end of the divided inferior vena cava, for control of portal hypertension, h-shunt anastomosis of the inferior vena cava to the superior mesenteric vein, using a synthetic conduit or autologous vein. (05 Mar 2000) |
| peritoneovenous shunt | An operation for the continuous emptying of ascitic fluid into the venous system. Fluid removal is based on intraperitoneal and intrathoracic superior vena cava pressure differentials and is performed via a pressure-sensitive one-way valve connected to a tube traversing the subcutaneous tissue of the chest wall to the neck where it enters the internal jugular vein and terminates in the superior vena cava. It is used in the treatment of intractable ascites. (12 Dec 1998) |
| right-to-left shunt | The passage of blood from the right side of the heart into the left (as through a septal defect), or from the pulmonary artery into the aorta (as through a patent ductus arteriosus); such a shunt can occur only when the pressure on the right side exceeds that in the left, as in advanced pulmonic stenosis, or when the pulmonary artery pressure exceeds aortic pressure, as in one form of Eisenmenger's syndrome or in tricuspid atresia. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|